109 related articles for article (PubMed ID: 26487364)
1. Synergistic Effect of Sorafenib and Radiation on Human Oral Carcinoma in vivo.
Hsu FT; Chang B; Chen JC; Chiang IT; Liu YC; Kwang WK; Hwang JJ
Sci Rep; 2015 Oct; 5():15391. PubMed ID: 26487364
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of sorafenib with ionizing radiation on human oral cancer cells.
Hsu FT; Chang B; Chiang IT; Wu TH; Hwang JJ
In Vivo; 2014; 28(5):925-33. PubMed ID: 25189909
[TBL] [Abstract][Full Text] [Related]
3. Sorafenib sensitizes human colorectal carcinoma to radiation via suppression of NF-κB expression in vitro and in vivo.
Kuo YC; Lin WC; Chiang IT; Chang YF; Chen CW; Su SH; Chen CL; Hwang JJ
Biomed Pharmacother; 2012 Feb; 66(1):12-20. PubMed ID: 22265104
[TBL] [Abstract][Full Text] [Related]
4. Sorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK/NF-κB signaling.
Hsu FT; Liu YC; Chiang IT; Liu RS; Wang HE; Lin WJ; Hwang JJ
Int J Oncol; 2014 Jul; 45(1):177-88. PubMed ID: 24807012
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel in combination with cetuximab exerts antitumor effect by suppressing NF-κB activity in human oral squamous cell carcinoma cell lines.
Harada K; Ferdous T; Kobayashi H; Ueyama Y
Int J Oncol; 2014 Dec; 45(6):2439-45. PubMed ID: 25230791
[TBL] [Abstract][Full Text] [Related]
6. Cepharanthin-enhanced radiosensitivity through the inhibition of radiation-induced nuclear factor-kappaB activity in human oral squamous cell carcinoma cells.
Tamatani T; Azuma M; Motegi K; Takamaru N; Kawashima Y; Bando T
Int J Oncol; 2007 Oct; 31(4):761-8. PubMed ID: 17786306
[TBL] [Abstract][Full Text] [Related]
7. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.
Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E
Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459
[TBL] [Abstract][Full Text] [Related]
8. SOX4 expression is associated with treatment failure and chemoradioresistance in oral squamous cell carcinoma.
Yoon TM; Kim SA; Cho WS; Lee DH; Lee JK; Park YL; Lee KH; Lee JH; Kweon SS; Chung IJ; Lim SC; Joo YE
BMC Cancer; 2015 Nov; 15():888. PubMed ID: 26555193
[TBL] [Abstract][Full Text] [Related]
9. Sorafenib potentiates irradiation effect in hepatocellular carcinoma in vitro and in vivo.
Yu W; Gu K; Yu Z; Yuan D; He M; Ma N; Lai S; Zhao J; Ren Z; Zhang X; Shao C; Jiang GL
Cancer Lett; 2013 Feb; 329(1):109-17. PubMed ID: 23142289
[TBL] [Abstract][Full Text] [Related]
10. Transcutaneous carbon dioxide enhances the antitumor effect of radiotherapy on oral squamous cell carcinoma.
Iwata E; Hasegawa T; Ueha T; Takeda D; Saito I; Kawamoto T; Akisue T; Sakai Y; Sasaki R; Kuroda R; Komori T
Oncol Rep; 2018 Jul; 40(1):434-442. PubMed ID: 29767262
[TBL] [Abstract][Full Text] [Related]
11. Curcumin synergistically enhances the radiosensitivity of human oral squamous cell carcinoma via suppression of radiation-induced NF-κB activity.
Chiang IT; Liu YC; Hsu FT; Chien YC; Kao CH; Lin WJ; Chung JG; Hwang JJ
Oncol Rep; 2014 Apr; 31(4):1729-37. PubMed ID: 24503718
[TBL] [Abstract][Full Text] [Related]
12. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
[TBL] [Abstract][Full Text] [Related]
13. Curcumin Sensitizes Hepatocellular Carcinoma Cells to Radiation via Suppression of Radiation-Induced NF-κB Activity.
Hsu FT; Liu YC; Liu TT; Hwang JJ
Biomed Res Int; 2015; 2015():363671. PubMed ID: 26539482
[TBL] [Abstract][Full Text] [Related]
14. Additive effect of radiosensitization by 2-deoxy-D-glucose delays DNA repair kinetics and suppresses cell proliferation in oral squamous cell carcinoma.
Kawata M; Ogi K; Nishiyama K; Miyamoto S; Nakagaki T; Shimanishi M; Miyazaki A; Hiratsuka H
J Oral Pathol Med; 2017 Nov; 46(10):979-985. PubMed ID: 28640935
[TBL] [Abstract][Full Text] [Related]
15. Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts.
Locatelli SL; Giacomini A; Guidetti A; Cleris L; Mortarini R; Anichini A; Gianni AM; Carlo-Stella C
Leukemia; 2013 Aug; 27(8):1677-87. PubMed ID: 23360848
[TBL] [Abstract][Full Text] [Related]
16. Nuclear factor kappa B-mediated CD47 up-regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in mice.
Lo J; Lau EY; Ching RH; Cheng BY; Ma MK; Ng IO; Lee TK
Hepatology; 2015 Aug; 62(2):534-45. PubMed ID: 25902734
[TBL] [Abstract][Full Text] [Related]
17. FAP-1 and NF-κB expressions in oral squamous cell carcinoma as potential markers for chemo-radio sensitivity and prognosis.
Nariai Y; Mishima K; Yoshimura Y; Sekine J
Int J Oral Maxillofac Surg; 2011 Apr; 40(4):419-26. PubMed ID: 21176871
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-92b promotes tumor growth and activation of NF-κB signaling via regulation of NLK in oral squamous cell carcinoma.
Liu Z; Diep C; Mao T; Huang L; Merrill R; Zhang Z; Peng Y
Oncol Rep; 2015 Dec; 34(6):2961-8. PubMed ID: 26503628
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous imaging of temporal changes of NF-κB activity and viable tumor cells in Huh7/NF-κB-tk-luc2/rfp tumor-bearing mice.
Wang WH; Chiang IT; Liu YC; Hsu FT; Chen HW; Chen CL; Lee YJ; Lin WJ; Hwang JJ
In Vivo; 2013; 27(3):339-50. PubMed ID: 23606689
[TBL] [Abstract][Full Text] [Related]
20. A sorafenib derivative and novel SHP-1 agonist, SC-59, acts synergistically with radiotherapy in hepatocellular carcinoma cells through inhibition of STAT3.
Huang CY; Tai WT; Hsieh CY; Hsu WM; Lai YJ; Chen LJ; Shiau CW; Chen KF
Cancer Lett; 2014 Jul; 349(2):136-43. PubMed ID: 24735751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
